SCHEMBL258101

SCHEMBL258101

CCCCCC/C=C\CCCCCCC(=O)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 3/20 0.71
PTPN1 P18031 3/20 0.71
PPARG P37231 3/20 0.71
PPARD Q03181 3/20 0.71
PPARA Q07869 3/20 0.71
FAAH O00519 3/20 0.71
MAPT P10636 2/20 0.71
BLM P54132 2/20 0.71
HSD17B10 Q99714 2/20 0.71
FABP4 P15090 2/20 0.71
F7 P08709 2/20 0.71
F3 P13726 2/20 0.71
GMNN O75496 1/20 0.71
USP2 O75604 1/20 0.71
LMNA P02545 1/20 0.71
CYP1A2 P05177 1/20 0.71
POLB P06746 1/20 0.71
CYP2C9 P11712 1/20 0.71
ALOX15 P16050 1/20 0.71
APEX1 P27695 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27460898 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL28580282 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL18340144 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL16006989 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL29947646 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL18340149 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL3240562 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL8367776 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL5670803 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA
SCHEMBL17136107 1.00 TERT (0.71) TERTPTPN1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103857793-A Biotechnological process for the synthesis of omega-functionalized carboxylic acids and esters from simple carbon sources EVONIK DEGUSSA GMBH 2014-06-11 CN disclosed
US-8063107-B2 Use of trans-pellitorin as flavor substance SYMRISE AG (DE) 2011-11-22 US disclosed
US-20100291005-A1 USE OF TRANS-PELLITORIN AS FLAVOR SUBSTANCE SYMRISE GMBH & CO. KG (DE) 2010-11-18 US disclosed
US-7776923-B2 Use of trans-pellitorin as flavor substance SYMRISE GMBH & CO. KG (DE) 2010-08-17 US disclosed
US-20040241312-A1 Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine SYMRISE AG (DE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100291005-A1 USE OF TRANS-PELLITORIN AS FLAVOR SUBSTANCE PTMA, TAS2R14, TAS2R16 TERT 1698/4885PTPN1 3593/4885PPARG 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.